Lonnel Coats - 28 Feb 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Lonnel Coats
Issuer symbol
LXRX
Transactions as of
28 Feb 2023
Net transactions value
-$110,607
Form type
4
Filing time
01 Mar 2023, 15:46:57 UTC
Previous filing
13 Feb 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +84,630 +14% 670,633 28 Feb 2023 Direct F1
transaction LXRX Common Stock Options Exercise +33,334 +5% 703,967 28 Feb 2023 Direct F1
transaction LXRX Common Stock Options Exercise +91,363 +13% 795,330 28 Feb 2023 Direct F1
transaction LXRX Common Stock Tax liability $110,607 -50,971 -6.4% $2.17 744,359 28 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -84,630 -100% 0 28 Feb 2023 Common Stock 84,630 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -33,334 -50% 33,333 28 Feb 2023 Common Stock 33,334 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -91,363 -33% 182,727 28 Feb 2023 Common Stock 91,363 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.